_________
false
אקס טי אל ביופרמסוטיקלס בע"מ
2
380
X T L BIOPHARMACEUTICALS LTD
Corporation no:
520039470
4313
Israel Securities Authority
Tel Aviv Stock Exchange
C002
(
Public
)
Reported via MAGNA:
11/08/2016
www.isa.gov.il
www.tase.co.il
Reference:
2016-02-102061
Time of broadcast:
16:20
15:47:01
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
a new patent application filing with the U.S. Patent and Trademark Office to protect doses of hCDR1 in the treatment of Systemic Lupus Erythematosus (SLE)
11_08_16_XTLB_6K_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
NASDAQ CM
Date of revision of form structure:
26/07/2016
Address:
HaCharoshet st
5
,
Ra'anana
43656
Israel
,
Tel:
09-9557080
,
Fax:
09-9519708
E-mail address:
ir@xtlbio.com
Company site:
www.xtlbio.com
Previous names of reporting entity:
XENOGRAFT TECHNOLOGIES LTD
Name of the Signatory:
Kntor Ronen
Position of Signatory in the reporting corporation:
Attorney/Legal Counsel
Name of Employer Company:
Address:
abba hillel
12
,
ramat gan
5250606
Telephone:
972-3613337
Facsimile:
03-6133372
E-mail:
rkantor@dtkgc.com
1